RLAY RELAY THERAPEUTICS INC

Ownership history in Blackstone Inc.  ·  17 quarters on record

This page tracks every 13F SEC filing in which Blackstone Inc. reported a position in RELAY THERAPEUTICS INC (RLAY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 35,618 0% 0.00% $186K $5.22
2025 Q2 UNCHANGED 35,618 0% 0.00% $123K $3.46
2025 Q1 UNCHANGED 35,618 0% 0.00% $93K $2.62
2024 Q4 UNCHANGED 35,618 0% 0.00% $147K $4.12
2024 Q3 UNCHANGED 35,618 0% 0.00% $252K $7.08
2024 Q2 UNCHANGED 35,618 0% 0.00% $232K $6.52
2024 Q1 UNCHANGED 35,618 0% 0.00% $296K $8.30
2023 Q4 UNCHANGED 35,618 0% 0.00% $392K $11.01
2023 Q3 UNCHANGED 35,618 0% 0.00% $300K $8.41
2023 Q2 UNCHANGED 35,618 0% 0.00% $447K $12.56
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RLAY price (monthly, adj. close)
← Back to Blackstone Inc. Holdings